Brandon Deck Email & Phone Number

San Diego, Ca, Us

San Diego, Ca, Us

Southern California

• Serve as the Precision Medicine commercial lead and expert for the implementation of the US precision medicine strategy in their region• Provide Precision Medicine expertise to cross-functional teams, focusing on prioritized barriers to biomarker testing and deployment of J&J IM Precision Medicine resources• Build relationships with critical physicians, population health decision makers, and pathologists to execute our Precision Medicine strategy aligned to the J&J IM current and future portfolio • Develop a deep understanding of the patient testing journey, testing landscape, and barriers to guidelines-based biomarker testing at the account level to identify opportunities for J&J IM to support improvement in testing practices• As a Precision Medicine representative for J&J IM, I present at external meetings with key stakeholders, including providers and access marketplace representatives.• Alongside SCG, support the efforts of J&J IM to impact access and coverage of comprehensive biomarker testing positively

West Region

As part of a cross-functional Vitrakvi field team, the Diagnostic Acct. Manager is responsible for cultivating stakeholder relationships and developing account-specific plans to facilitate the uptake of high-quality, comprehensive tumor biomarker/genomic testing that includes TRK fusion• Provide education and support around oncology diagnostic testing (Immunohistochemistry, NGS, FISH) and how it fits in the treatment paradigm of TRK fusion and other genomically defined tumors• Enhance in-house testing capabilities through the addition of NTRK-enabled testing methods• Drive & optimize NTRK-enabled testing through the development of tumor-specific testing pathway protocols and EMR integration• Increase awareness of NTRK fusions, precision medicine, test methodologies, and actionable biomarker landscape through education of key stakeholders• Facilitate customer hand-off opportunities with cross-functional field team, as well as with external parties (third-party lab and/or IVD company) parties as appropriate.• Interim National Diagnostic Director (April 2021-December 2021) STA (short-term assignment).• Developed ‘Perspectives in Precision Medicine Program’ within the Providence Health System – April 2021. ~100 attendees included Providence HCPs and the Bayer team. The program was recorded and accessible to HCPs within the Providence Health Portal to continue to drive adoption of testing all metastatic patients early with their NGS-based TSO500 panel.• Thyroid IRB approved protocol at UCSF in collaboration with UCSF thyroid cancer department in efforts to increase Thyroid cancer testing at UCSF. Resulted in 4-6 new Vitrakvi patients. UCSF is currently up 77% year over year.• Connected with Molecular Lab Director at UCLA to help validate and create an in-house fusion panel that includes NTRK 1-3. Resulted in UCLA growing year over year >600% growth.

San Diego, Inland Empire, Hawaii

Promoted Foundation One CDX & Foundation One Liquid - molecular profiling assays for all solid tumors such as breast, lung, and colon cancer which detects all four classes of genomic alterations: Foundation One-Heme, a hematologic molecular profiling assay for hematologic cancers (leukemia, lymphoma and myeloma), as well as many sarcomas and pediatric cancers.• Supported launch of all new technology products/services (i.e. ICE 2.0, Federated Data Model, etc.) to drive adoption and usage. • Marketing Insights Account Leader – collaborations with marketing to develop territory-focused collateral • Account Plan Manager – key strategies with development of nationwide account plan for Acct. Executives to utilize in the field• Key collaboration development with UCSD Clinical Trial sites with patient participation to date• Direct execution of product sales strategies and tactics, and implementation of sales and marketing plans within territory.• Drove growth and customer advocacy for strategic payers by targeting KOLs, AMCs, appropriate Community Oncology Practices, and Key Strategic Accounts.• Developed business solutions that are applied to broader business scenarios and customer-focused models to achieve breakthrough results.• Identified client-bill contracting opportunities with academic medical centers, large cancer centers, health systems, and other strategically important key accounts.• Increased physician senders from 35 to 77 across territory Q1 2015.• #1 ranked Academic institution with cases received in the nation 2015-2017.• Recruited 3 KOL’s for nationwide speaker’s bureau and only pathologist speaker nationally.• President’s club 2014 & 2015, promoted to Senior Account Executive in 2015.

Southern California

Promoted FISH-based assays and biomarkers; PathVysion that includes ER, PR, P53, Ki67 by IHC, HER2/neu by Fish, HER2/neu by IHC., FDA approved UroVysion, and other biomarkers such as ALK, ROS1, EGFR, BRAF, KRAS, PTEN, and ERG• Developed and executed on account-specific strategies for every target within the assigned territory• Expanded reagent use in existing physician-owned laboratories, and prospected, developed, and closed contracts with new physician-owned laboratories• Ranked #2 out of 15 sales reps nationwide.• Presidents Club 2013.

Los Angeles/ San Fernando/ San Diego

Offered genetic testing that helped assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.• Promoted genetic testing - BracAnalysis for hereditary breast cancer, Colaris for hereditary colon cancer, Melaris for hereditary melanoma; the presence of which would indicate an increased risk of cancer.• Promoted Theraguide 5FU – a blood test to minimize side effects, and Ondose – a blood test to optimize dosing for colon cancer patients.• Position includes sharing of information with the organization including feedback on current marketing programs, potential new tests for Myriad, and creative idea concepts that have been implemented in the territory.• Collaborated with specialists within academia to increase access to genetic testing for patients and increase sample flow.• Managed Care Product Advisor January 2007.• Imaging Center Champion March 2011.• Promoted to Senior Oncology Sales Specialist November 2010.• Promoted to Oncology Product Specialist in July 2008 • Outstanding Individual Performance: Thera guide Product Launch 2008.• Certificate of Appreciation and Implementation: On dose Product Launch 2009.• Implemented genetic testing into the first Imaging Center in California in 2011.• Implemented genetic testing into the first Military Base in California in 2011.• Within 2 years brought territory rank from #83 to top 20 in the nation in Oncology.• Brought territory #120 to top 50 within 9 months in the Preventative Care division.• Ranked #35 out of 204 representatives nationwide in 2009.• Mentored and trained all new sales representatives.• Trained in Franchise Management principles and implemented within current territory.

Greater San Diego Area

• Marketed significantly discounted domestic/international air and ground services to small and medium sized businesses (SMB) by offering unmatched service levels and superior value to customers.• Created a loyal customer base by providing tailored invoicing, automation, and customer service solutions typically reserved for the fortune 500 companies.• Billed over $10,000 in gross revenue, Ranked top 20 in the nation.• Territory encompassed all of San Diego county

Bachelor Of Arts (B.A.), Public Relations/Marketing

Minor, Spanish Language And Literature

Education record